Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Stanford University
University of Virginia
Fusion Pharmaceuticals Inc.
Thomas Jefferson University
Nuvation Bio Inc.
Actym Therapeutics, Inc.
Taiho Oncology, Inc.
Vall d'Hebron Institute of Oncology
Sanofi
Eli Lilly and Company
University of Pennsylvania
Cancer Trials Ireland
University of Virginia
Sanofi
Lyell Immunopharma, Inc.
Dana-Farber Cancer Institute
Mayo Clinic
Massachusetts General Hospital
Pfizer
M.D. Anderson Cancer Center
Black Diamond Therapeutics, Inc.
Turnstone Biologics, Corp.
Tvardi Therapeutics, Incorporated
Accutar Biotechnology Inc
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
NantBioScience, Inc.
Medical University of South Carolina
Hoffmann-La Roche
Pfizer
GlaxoSmithKline
Pfizer
Merck Sharp & Dohme LLC
Kyowa Kirin Co., Ltd.
Ikena Oncology
Ikena Oncology
Haihe Biopharma Co., Ltd.
Eisai Inc.
OHSU Knight Cancer Institute
Accutar Biotechnology Inc
Atreca, Inc.
Leap Therapeutics, Inc.
Boehringer Ingelheim
Fate Therapeutics
Nuvation Bio Inc.
Oncorus, Inc.
Pfizer
Novartis
Aileron Therapeutics, Inc.
University of Virginia